12.29.20

Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi

Source: Eyenovia

12.16.20

Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopia

Source: Eyenovia

12.03.20

FDA Approves Eyenovia’s IND Application for MicroLine for Presbyopia, Allowing for Phase 3 Trials

Source: Eyenovia

08.11.20

Eyenovia and Arctic Vision Announce License Agreement to Develop and Commercialize Products in Greater China and South Korea

Source: Eyenovia

10.29.19

Eyenovia Advances MicroLine for the Treatment of Presbyopia; Reprioritizes Late-Stage Ophthalmology Pipeline

Source: Eyenovia

View more stories